Summary
- Current Price
- As of today, AIM price is $1.25, up +58.23% on
- Current Price All-Time High
- AIM price is currently -100.00% below its historical high of $973,035.88 set on
- Market Cap
- AIM current market cap is $4M, down -57.18% year-over-year
- PE Ratio
- AIM PE ratio is unknown
- Revenue
- AIM current annual revenue is $170.00K, down -15.84% year-over-year
- Next Earnings
- As of today, the next earnings release for AIM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | AIM ImmunoTech Inc. |
| Ticker | NYSEAmerican: AIM |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aimimmuno.com |
| Employees | 21 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.25 | ||
| Price, 1D Change | +58.23% | |
| $4M | ||
| - | ||
| - | ||
| 1.45 | ||
| $170K | ||
| Revenue, 1Y Change | -15.84% | |
| -$30.89 | ||
| EPS, 1Y Change | -5,081.70% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1031:1000 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AIMI | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$30.89 | ||
| EPS Estimate | N/A | -$7.74 |
| EPS Est. Change | N/A | +74.93% |
| $170.00K | ||
| Revenue Estimate | N/A | $100.00K |
| Revenue Est. Change | N/A | -41.18% |
| $1.25 | ||
| Price Target | - | $13.99 |
| Price Tgt. Change | - | +1,018.88% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.48 | -$0.60 | -24.19% | |
| -$0.30 | -$30.89 | -10,196.03% | |
| -$7.74 | N/A | +74.93% | |
| -$4.33 | N/A | +86.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $160.00K | $202.00K | +26.25% | |
| $200.00K | $170.00K | -15.00% | |
| $100.00K | N/A | -41.18% | |
| $50.00K | N/A | -70.59% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -90.79% | ||
| -97.57% | ||
| -57.18% | ||
| -83.83% | ||
| -15.84% | ||
| +25.93% | ||
| -5,081.70% | ||
| -7,545.57% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.25 | ||
| $3.88 | ||
| SMA 200 vs Price | +210.63% | |
| $1.22 | ||
| SMA 50 vs Price | -2.28% | |
| 1.45 | ||
| $0.19 | ||
| 54.89 | ||
| 343.52% | ||
| 183.09% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $170.00K | ||
| -$30.89 | ||
| -$107.00K | ||
| -62.94% | ||
| -$19.77M | ||
| -11.63% | ||
| -$17.32M | ||
| -10.19% | ||
| -$16.49M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.75 | ||
| 0.44 | ||
| 0.44 | ||
| - | ||
| 2 | ||
| -12.75 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 35.73 | ||
| -0.66 | ||
| -0.29 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$1.32M | ||
| $1.70M | ||
| $51.49M | ||
| $4.18M | ||
| $52.81M | ||
| $9.54M | ||
| $2.94M | ||
| $2.55M | ||
| $6.38M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $19.94M | ||
| $19.91M | ||
| $277.00K | ||
| $13.71M | ||
| $246.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$14.89M | ||
| $4.71M | ||
| $6.44M | ||
| $556.00K | ||
| -$15.44M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Ascendiant Capital | → | |
| Maxim Group | → | |
| Ascendiant Capital | → | |
| Maxim Group | → |
Analyst sentiment
Institutional ownership
Screeners with AIM
FAQ
What is the ticker symbol for AIM ImmunoTech Inc.?
The ticker symbol for AIM ImmunoTech Inc. is NYSEAmerican:AIM
Does AIM ImmunoTech Inc. pay dividends?
No, AIM ImmunoTech Inc. does not pay dividends
What sector is AIM ImmunoTech Inc. in?
AIM ImmunoTech Inc. is in the Healthcare sector
What industry is AIM ImmunoTech Inc. in?
AIM ImmunoTech Inc. is in the Biotechnology industry
What country is AIM ImmunoTech Inc. based in?
AIM ImmunoTech Inc. is headquartered in United States
When did AIM ImmunoTech Inc. go public?
AIM ImmunoTech Inc. initial public offering (IPO) was on November 2, 1995
Is AIM ImmunoTech Inc. in the S&P 500?
No, AIM ImmunoTech Inc. is not included in the S&P 500 index
Is AIM ImmunoTech Inc. in the NASDAQ 100?
No, AIM ImmunoTech Inc. is not included in the NASDAQ 100 index
Is AIM ImmunoTech Inc. in the Dow Jones?
No, AIM ImmunoTech Inc. is not included in the Dow Jones index
When was AIM ImmunoTech Inc. last earnings report?
AIM ImmunoTech Inc.'s most recent earnings report was on August 15, 2025
When does AIM ImmunoTech Inc. report earnings?
The date for AIM ImmunoTech Inc.'s next earnings report has not been announced yet
Data Sources & References
- AIM Official Website aimimmuno.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/946644/000164117225000847/0001641172-25-000847-index.htm
- AIM Profile on Yahoo Finance finance.yahoo.com/quote/AIM
- AIM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aim